Marvell (MRVL) is evolving into a pure-play AI infrastructure leader. Data center revenue is now 74% of total and ...
Grew 8.2% year over year to $52.7 million, accounting for 80% of total revenue, with growth attributed to both digital ...
YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced its ...
Transaction volume guidance -- Q2 guided to 300 to 350 transactions and $80 million to $90 million in revenue, targeting a ...
Revolution Medicines outlines $1.6B–$1.7B 2026 operating expenses as RAS(ON) inhibitor trials expand
Feb 25, 2026, 9:18 PM ETRevolution Medicines, Inc. (RVMD) Stock, RVMDW StockAI-Generated Earnings Calls Insights ...
NEW YORK, April 15, 2026 /PRNewswire/ -- Theravance Biopharma (NASDAQ: TBPH) shareholders lost approximately 26% of their investment on March 3, 2026, when the Company disclosed that its Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results